Lv3
258 积分 2022-03-17 加入
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
2小时前
已完结
T-cell engager antibodies enable T cells to control HBV infection and to target HBsAg-positive hepatoma in mice
1个月前
已完结
Chimeric antigen receptors of HBV envelope proteins inhibit hepatitis B surface antigen secretion
1个月前
已完结
Chimeric antigen receptors of HBV envelope proteins inhibit hepatitis B surface antigen secretion
1个月前
已完结
The scientific basis of combination therapy for chronic hepatitis B functional cure
2个月前
已完结
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV
2个月前
已完结
In-vitro and in-vivo models for hepatitis B cure research
2个月前
已完结
Therapeutic potential of stem cells in regeneration of liver in chronic liver diseases: Current perspectives and future challenges
2个月前
已完结
Pluripotent stem cell-based cardiac regenerative therapy for heart failure
3个月前
已完结
Potential of Mesenchymal Stem Cell-Based Therapies for Pulmonary Fibrosis
3个月前
已完结
皖公网安备34019202002308
